The reported effects on the MM-associated increase in the proinflammatory cytokine IL-17A48 and the positive effect of this cytokine on MM growth45, lend support to the notion that EPO-mediated reduction in Th17 parameters contributes to the attenuation of MM. This evidence concerns the gene EPO and Miyoshi myopathy.